Hansa Biopharma To Be Transformed By Idefirix Approval In EU
Launch In Selected Markets In The Fourth Quarter
With the first approval in the bag for its lead product, Idefirix, from the European Commission, Sweden’s Hansa Biopharma is planning to launch the product in Europe using its own medical and commercial organization in core markets.
